Author | Andrew Zhu, MD, PhD | OncLive

Author | Andrew Zhu, MD, PhD

Articles

Dr. Andrew Zhu on Ramucirumab for HCC

July 03, 2015

Andrew Zhu, MD, PhD, Associate Professor, Medicine, Harvard Medical School Director, Liver Cancer Research, Medicine, Massachusetts General Hospital, discusses the REACH study, which looks at ramucirumab in advanced hepatocellular carcinoma.

x